Purchase Order 36C26326P0229
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23) awarded Edwards Lifesciences LLC a $34,000 firm fixed-price purchase order for transcatheter aortic valve replacement (TAVR) systems on January 16, 2026, with an ultimate completion date of January 20, 2026. The contract, which carries no set-aside designation, supports the VA's mission to provide specialized cardiac care to veterans in the Minneapolis service area. Edwards Lifesciences LLC, a subsidiary of...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis VA) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of January 20, 2026. This contract, awarded on January 16, 2026, carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced cardiovascular medical devices to the Department of Veterans Affairs. The award is structured as a...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network (VISN) 23, a civilian component of the U.S. Department of Veterans Affairs, on December 19, 2025. The contract, which has no set-aside designation, is for TAVR (Transcatheter Aortic Valve Replacement) devices and will be performed in Minneapolis, Minnesota, with an ultimate completion date of December 22, 2025. As a subsidiary of Edwards Lifesciences Corporation and a recognized...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC on January 12, 2026, for transcatheter aortic valve replacement (TAVR) equipment and related cardiovascular devices. The contract, which carries no set-aside designation, is scheduled for completion by January 15, 2026, with performance taking place in Minneapolis, Minnesota. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) products on December 5, 2025, with completion scheduled for December 8, 2025. This contract, which carries no set-aside designation, will be performed in Minneapolis, Minnesota. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a for-profit limited liability company, for $34,000. The contract is for the delivery of transcatheter aortic valve replacement (TAVR) products and services, with a completion date of November 18, 2024. No set-aside designation was used. Edwards Lifesciences LLC is a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business. The...
- Edwards Lifesciences LLC was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on January 12, 2026, for transcatheter aortic valve replacement (TAVR) medical devices. The contract, which carries no set-aside designation, is scheduled for completion by February 11, 2026, with performance taking place in Minneapolis, Minnesota. As a subsidiary of Edwards Lifesciences Corporation, a global leader in structural heart disease treatment, the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical device innovation, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on November 7, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota with an ultimate completion date of November 10, 2025. This award carries no set-aside designation and...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis) on January 30, 2026, for transcatheter aortic valve replacement (TAVR) systems. The contract, with an ultimate completion date of March 1, 2026, carries no set-aside designation and represents a sole-source procurement reflecting the contractor's exclusive...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC on November 21, 2025, with an ultimate completion date of November 24, 2025. This contract, which carries no set-aside designation, is for transcatheter aortic valve replacement (TAVR) medical devices to support veteran healthcare at the Minneapolis, Minnesota facility. Edwards Lifesciences LLC, a subsidiary of Edwards...
This purchase order, awarded January 30, 2026, provides Edwards Lifesciences LLC with $34,000 to supply transcatheter aortic valve replacement (TAVR) systems to Veterans Integrated Service Network 23 in Minneapolis, Minnesota. The contract is structured as a firm fixed-price purchase order with a completion date of February 2, 2026, and carries no set-aside designation. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, is the sole awardee and specializes in advanced cardiovascular medical devices including transcatheter heart valves and related cardiac technologies essential to the Department of Veterans Affairs' cardiac care programs. This award is part of Edwards Lifesciences LLC's extensive business relationship with the VA healthcare system, which encompasses over 200 federal contract awards since 2025 and two significant Indefinite Delivery Contracts—a $6.5 million five-year IDV with VISN 21 for surgical implant consignment services and a $950,000 five-year IDV with VISN 15 for heart valves and cardiovascular devices. The company's procurement volumes are particularly concentrated within VISN 23 (Minneapolis), VISN 21 (Palo Alto/San Francisco), and VISN 17 (Houston/Dallas), with individual purchase orders typically ranging from approximately $11,000 to $238,000. The awards reflect Edwards Lifesciences LLC's exclusive manufacturing capability for specialized cardiac technologies and the critical role these devices play in supporting veteran patient outcomes across the VA system.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6515--PROS V23 618 UNU BILL & REPLACE 62724 (MI) TAVR (NEED ON OR BEFORE 2/03/2026) (VA-26-00041599) | 36C26326Q0319 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 | Award Notice 1/1 | 1/30/26, 11:34 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 1/30/26 |